Parexel saw shares drop 4.3% after releasing information on the embezzlement of corporate funds at one of the company’s international operations in an SEC filing.
Get the full story at our sister site, Medical Design & Outsourcing.
Home » Parexel shares slide on embezzlement news
In case you missed it
- Heraeus can pursue trade secret suit against Zimmer Biomet supplier
- Zeiss invests in MicroOptx
- Medtronic put up $316m for Epix Therapeutics
- Avinger pulls the trigger on 1-10 reverse split
- Rethinking orthopedic implants with Arthrosurface CEO Steve Ek | DeviceTalks Podcast
- CMS expands TAVR coverage
- Obalon readies $17m offering for retail pivot
- Novanta to acquire Arges
- Corinth MedTech raises $12m for Veloxion urology device
- Medtronic readies $4B debt tender
- Royal Philips to open R&D center in Rochester, Minn.
- 8 medical device industry supplier innovations you need to know
- JenaValve adds $15m for TAVR device
- FDA formally ends secret alternative reporting of adverse events
- Two deaths reported in recall of 6 million Teleflex endotracheal tubes
- Fresenius OKs $748m stock buyback
- FDA panel wants more, better data on paclitaxel-eluting devices
MassDevice Network
@MassDevice
LinkedIn
YouTube
Leave a Reply
You must be logged in to post a comment.